Greg Tourangeau - 15 Jul 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Controller
Signature
/s/ Gregory Tourangeau
Issuer symbol
FULC
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 16:15:26 UTC
Previous filing
10 May 2022
Next filing
13 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +16,540 $0.000000 16,540 15 Jul 2022 Common Stock 16,540 $5.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 15, 2022 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2022, subject to the reporting person's continued service on each such vesting date.

Remarks:

Exhibit Index: 24.1 Power of Attorney